GI Stool Testing Market Size to Hit USD 5.02 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on GI Stool Testing Market

5.1. COVID-19 Landscape: GI Stool Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global GI Stool Testing Market, By Test Type

8.1. GI Stool Testing Market Revenue and Volume, by Test Type

8.1.1. Occult Blood Test (FOBT, FIT)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Microbial Testing

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Calprotectin & Inflammatory Markers

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Molecular Diagnostics

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Gut Microbiome Testing

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global GI Stool Testing Market, By Technology

9.1. GI Stool Testing Market Revenue and Volume, by Technology

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Lateral Flow Assay (LFA)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Enzyme-Linked Immunosorbent Assay (ELISA)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Polymerase Chain Reaction (PCR)

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Next Generation Sequencing (NGS)

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Mass Spectrometry

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global GI Stool Testing Market, By Application

10.1. GI Stool Testing Market Revenue and Volume, by Application

10.1.1. Infectious Gastroenteritis

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Colorectal Cancer Screening

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Inflammatory Bowel Disease (IBD)

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Irritable Bowel Syndrome (IBS)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Nutritional Malabsorption Disorders

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Gut Microbiome Health Assessment

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast

Chapter 11. Global GI Stool Testing Market, By Sample Collection Method

11.1. GI Stool Testing Market Revenue and Volume, by Sample Collection Method

11.1.1. At-home Sample Collection Kits

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Hospital / Laboratory Collection

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global GI Stool Testing Market, By End User

12.1. GI Stool Testing Market Revenue and Volume, by End User

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Diagnostic Laboratories

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Academic & Research Institutions

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Homecare / Individual Users

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Others

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global GI Stool Testing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Test Type

13.1.2. Market Revenue and Volume Forecast, by Technology

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Test Type

13.1.6.2. Market Revenue and Volume Forecast, by Technology

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.1.6.5. Market Revenue and Volume Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Test Type

13.1.7.2. Market Revenue and Volume Forecast, by Technology

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Test Type

13.2.2. Market Revenue and Volume Forecast, by Technology

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.2.5. Market Revenue and Volume Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Test Type

13.2.6.2. Market Revenue and Volume Forecast, by Technology

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by Sample Collection Method

13.2.8. Market Revenue and Volume Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Test Type

13.2.9.2. Market Revenue and Volume Forecast, by Technology

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by Sample Collection Method

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Test Type

13.2.12.2. Market Revenue and Volume Forecast, by Technology

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Test Type

13.2.14.2. Market Revenue and Volume Forecast, by Technology

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Test Type

13.3.2. Market Revenue and Volume Forecast, by Technology

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Test Type

13.3.6.2. Market Revenue and Volume Forecast, by Technology

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Test Type

13.3.8.2. Market Revenue and Volume Forecast, by Technology

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Test Type

13.3.10.2. Market Revenue and Volume Forecast, by Technology

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Test Type

13.3.11.2. Market Revenue and Volume Forecast, by Technology

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Test Type

13.4.2. Market Revenue and Volume Forecast, by Technology

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Test Type

13.4.6.2. Market Revenue and Volume Forecast, by Technology

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Test Type

13.4.8.2. Market Revenue and Volume Forecast, by Technology

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Test Type

13.4.10.2. Market Revenue and Volume Forecast, by Technology

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Test Type

13.4.11.2. Market Revenue and Volume Forecast, by Technology

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Test Type

13.5.2. Market Revenue and Volume Forecast, by Technology

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Test Type

13.5.6.2. Market Revenue and Volume Forecast, by Technology

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Test Type

13.5.8.2. Market Revenue and Volume Forecast, by Technology

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by Sample Collection Method

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. BioFire Diagnostics (bioMérieux)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. QuidelOrtho Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Becton, Dickinson and Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Becton, Dickinson and Company

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Hologic, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Alere Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Promega Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Siemens Healthineers

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Biomerica, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DayTwo

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The GI stool testing market size is expected to increase from USD 2.93 billion in 2024 to USD 5.02 billion by 2034.

The GI stool testing market is expected to grow at a compound annual growth rate (CAGR) of around 5.53% from 2025 to 2034.

The major players in the GI stool testing market include Exact Sciences Corporation, BioFire Diagnostics (bioMérieux), QuidelOrtho Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Roche Diagnostics, Hologic, Inc., CerTest Biotec, Alere Inc., Genova Diagnostics, Diagnostic Solutions Laboratory, Promega Corporation, Biomerica, Inc., Gastrointestinal Diagnostic Laboratory (GDX), Biomerieux SA, Siemens Healthineers, MyBioma, DayTwo, and Seegene Inc.

The driving factors of the GI stool testing market are the rise of gastrointestinal infections, inflammatory bowel disease, and colorectal cancer is a factor driving demand for accurate stool-based diagnostic tests to ensure potential issues are detected and treated promptly

North America region will lead the global GI stool testing market during the forecast period 2025 to 2034.